Polygenic risk of Alzheimer disease is associated with early- and late-life processes

Elizabeth C. Mormino(Allen Institute for Brain Science), Robert A. Koeppe(University of Michigan), Enchi Liu(University of Washington), Arthur W. Toga(University of California, Los Angeles), Danielle Harvey(UC San Diego Health System), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), John Q. Trojanowki(University of Southern California), Mert R. Sabuncu(Cornell University), Andrew J. Saykin(Alzheimer’s Disease Neuroimaging Initiative), Tamie Sather(University of California San Diego), John Kornak(University of California, San Francisco), Michael Donohue(Alzheimer’s Disease Neuroimaging Initiative), Tom Montine(University of Washington), Michael D. Weiner(University of California San Diego), Charles DeCarli(University of California Davis Medical Center), Dan Bandy(Alzheimer's Association), Ronald G. Thomas(UC San Diego Health System), Norbert Schuff(University of California, Davis), Jordan W. Smoller(Massachusetts General Hospital), Sarah Walter(UC San Diego Health System), Joel P. Felmlee(Mayo Clinic), Randy L. Buckner(Harvard University), Philip L. De Jager(Broad Institute), Laurel Beckett(Brigham and Women's Hospital), John C. Morris(Washington University in St. Louis), Matt A. Bernstein(University of London), Anders M. Dale(J. Craig Venter Institute), Paul M. Thompson(University of Southern California), Robert C. Green(Boston University), Ronald Petersen, Avram J. Holmes(Rutgers, The State University of New Jersey), Anthony Gamst(University of San Diego), Devon Gessert(UC San Diego Health System), Reisa A. Sperling(Harvard University), Paul Aisen(University of Southern California), Gene Alexander
Neurology
July 7, 2016
Cited by 196


Related Papers